BioSniper
ZH
Toggle language
Open menu
Patent Expiry
Patent/Exclusivity Expiry: ICOTYDE
November 19, 2041
Company
Protagonist Therapeutics, Inc (PTGX)
Drug
ICOTYDE
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
PTGX Overview
PDUFA Dates
Phase 3 Readouts
Patent/Exclusivity Expiry: ICOTYDE — PTGX Patent Expiry | BioSniper